Source Bioscience

Source BioScience is an international provider of integrated laboratory services to healthcare, pharmaceutical and life science clients. Its work spans digital pathology, artificial intelligence, histopathology, cell pathology, molecular diagnostics, genomics, precision medicine and stability storage, with a stated aim of improving patient diagnosis, management and care.

The company operates through four core business units: Healthcare Diagnostics, Genomics, Stability Storage and Precision Medicine. Healthcare Diagnostics covers end-to-end clinical services including cell and digital pathology, histopathology and molecular diagnostics. Genomics laboratory services are delivered under the Source Genomics name.

Source LDPath, acquired in 2021, provides histopathology and digital pathology services and expanded the network of specialist consultant pathologists registered with the Royal College of Pathologists and the General Medical Council. The unit focuses on digital pathology and AI technology.

Clients include blue-chip biopharma companies, the UK National Health Service and private hospitals. The company works in partnership with biotechnology, pharmaceutical, healthcare and academic institutions, and has an international presence with a base in the United Kingdom.